Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
102.17B | 96.29B | 87.17B | 71.41B | 57.41B | 61.22B | Gross Profit |
17.84B | 16.67B | 14.26B | 11.80B | 9.41B | 9.22B | EBIT |
1.61B | 1.63B | 2.14B | 1.15B | -83.38M | -70.22M | EBITDA |
5.58B | 6.21B | 7.34B | 5.76B | 3.08B | 3.46B | Net Income Common Stockholders |
39.92M | 408.99M | 1.21B | 660.23M | -315.16M | -910.38M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.79B | 4.79B | 7.01B | 5.92B | 7.38B | 6.04B | Total Assets |
85.11B | 85.11B | 79.24B | 70.42B | 63.61B | 63.57B | Total Debt |
31.75B | 30.19B | 27.88B | 25.05B | 22.12B | 21.45B | Net Debt |
27.76B | 25.41B | 20.88B | 19.13B | 14.75B | 15.42B | Total Liabilities |
51.83B | 51.83B | 47.24B | 40.64B | 36.02B | 35.40B | Stockholders Equity |
22.85B | 22.85B | 22.07B | 21.15B | 19.99B | 20.28B |
Cash Flow | Free Cash Flow | ||||
761.57M | -2.77B | -122.73M | -4.59B | 161.88M | 109.05M | Operating Cash Flow |
6.80B | 2.15B | 3.42B | -958.82M | 2.78B | 4.38B | Investing Cash Flow |
-6.10B | -4.91B | -3.15B | -2.47B | -1.86B | -4.17B | Financing Cash Flow |
-188.83M | 379.69M | 635.56M | 1.81B | 194.86M | 12.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥4.38B | 8.10 | 3.52% | 0.23% | -14.50% | ||
70 Outperform | ¥3.73B | 15.79 | 4.36% | 9.25% | -45.40% | ||
66 Neutral | ¥3.58B | 7.89 | 4.89% | 3.82% | ― | ||
64 Neutral | ¥4.30B | 7.25 | 4.94% | 7.71% | 44.35% | ||
62 Neutral | $6.94B | 11.29 | 2.95% | 3.87% | 2.70% | -24.49% | |
61 Neutral | ¥4.74B | 26.43 | 4.33% | -1.72% | ― | ||
39 Underperform | ¥3.64B | ― | ― | 33.86% | 69.12% |